Aurobindo Pharma Shares Surged 3% as Arm Signs a Pact with MSD – Equitypandit
Shares of Aurobindo Pharma Ltd were trading 3% higher on 3 June after the company’s wholly-owned subsidiary, TheraNym Biologics, signed a master service agreement for contract manufacturing of biologicals with Merck Sharpe & Dohme Singapore. As a part of this agreement, TheraNym will produce biologics for both domestic and international markets on behalf of Merck…